Expression of p27, p21WAF/Cip1, and p16INK4a in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2799-2803

  Queiroz, Ana Beatriz ^a   Focchi, Gustavo ^a   Dobo, Cristine ^a   Gomes, Thiago S ^a   Ribeiro, Daniel A ^a   Oshima, Celina T F ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Oral squamous cell carcinoma; Oral squamous papilloma; p16; p21; p27

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ARTICLE; CELL ASSAY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; ORAL SQUAMOUS PAPILLOMA; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; STAINING;

CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; MOUTH NEOPLASMS; PAPILLOMA; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 77955809475     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sittel C, Ruiz S, Volling P, Kvasnicka HM, Jungehulsing M and Eckel HE: Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity. Oral Oncol 35: 583-589, 1999. (Pubitemid 29506985)
2. Gleich LL and Salamone FN: Molecular genetics of head and neck cancer. Cancer Control 9: 369-378, 2002. (Pubitemid 35204459)
3. Okazaki Y, Tanaka Y, Tonogi M and Yamane G: Investigation of environmental factors for diagnosing malignant potential in oral epithelial dysplasia. Oral Oncol 55: 562-573, 2002.
4. Kudo Y, Takata T, Ogawa I, Zhao M, Sato S, Takekoshi T, Miyauchi M and Nikai H: Reduced expression of p27(kip1) correlates with an early stage of cancer invasion in oral squamous cell carcinoma. Cancer Lett 151: 217-222, 2000. (Pubitemid 30156797)
5. Regezi JÁ and Sciuba JJ: Patologia Bucal-Correlações Clinicopatológicas. Rio de Janeiro: Guanabara/Koogan, 1999 (in Portuguese).
6. Reszec J, Sulkowska M, Famulski W, Guzinska-Ustymowicz K and Sulkowski S: The expression of tumorigenesis markers in oral papilloma. Pol J Pathol 53: 195-200, 2002. (Pubitemid 36193758)
7. Ribeiro D, Narikawa S and Marques ME: Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin. Pathol Res Pract 204: 97-104, 2008.
8. WAF1/CIP1 expression in invasive fronts of oral tongue squamous cell carcinomas is correlated with tumor progression and poor prognosis. Oncol Rep 14: 837-846, 2005.
9. Hill R, Bodzak E, Blough MD and Lee PW: p53 binding to the p21 promoter is dependent on the nature of DNA damage. Cell Cycle 7: 2535-2543, 2009.
10. WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells. Mol Cancer 4: 41-46, 2005.
11. WAF/Cip1) and their relation to p53 and ki-67 in oral squamous tumorigenesis. Int J Oncol 22: 409-414, 2003.
12. Freer E, Savage NW, Seymour GJ, Dunn TL, Lavin MF and Gardiner RA: Ras oncogene product expression in normal and malignant oral mucosa. Aust Dent J 55: 141-146, 1990.
13. WAF/Cip1 expression in oral premalignant lesions and squamous cell carcinoma in Taiwan. J Oral Pathol Med 24: 255-260, 1995.
14. WAF/Cip1 and p185 in benign and malignant epithelia of cheek mucosa. Hua Xi Kou Qiang Yi Xue za Zhi 76: 20-22, 1998.
15. Hogmo A, Lindskog S, Lindholm J, Kuylenstierna R, Auer G and Munck-Wikland E: Preneoplastic oral lesions: the clinical value of image cytometry DNA analysis, p53 and p21/WAF1 expression. Anticancer Res 75: 3645-50, 1998. (Pubitemid 28564241)
16. Riese U, Dahse R, Fiedler W, Theuer C, Koscielny S, Ernst G, Beleites E, Claussen U and von Eggeling F: Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer. Int J Mol Med 4: 61-65, 1999.
17. INK4a, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. Oral Surgery Oral Med Oral Pathol Med 25: 226-232, 1999. (Pubitemid 29188411)
18. INK4A, a new marker that correlates with dysplasia in oral squamoproliferative lesions. Am J Surg Pathol 29: 792-796, 2005. (Pubitemid 40734428)
19. INK4a in dysplastic lesions of the oral cavity. Mod Pathol 23: 102-105, 2006.
20. Yakushiji T, Uzaka K, Shibara T, Noma H and Tanzawa H: Overexpression of DNA methyltransferases and CDKN2 gene methylation status in squamous cell carcinoma of the oral cavity. Int J Oncol 22: 1201-1217, 2003.
21. Soni S, Kaur J, Kumar A, Chakravarti N, Mathur M, Bahadur S, Shukla NK, Deo SV and Ralhan R: Alterations of RB pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oral Oncol 65: 314-325, 2005.
22. INK4a gene in normal oral mucosa of smokers. Int J Mol Med 14: 807-814, 2004.
23. kip1 in epithelial dysplasia and carcinoma of the oral cavity. Am J Patholol 152: 585-590, 1998. (Pubitemid 28106405)